A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria

키워드

참고문헌 (10)

1. Weller K, "Selected urticaria patients benefit from a referral to tertiary care centres--results of an expert survey", J Eur Acad Dermatol Venereol, 27, pp.e8~e16 (2013)
2. Zuberbier T, "EAACI", GA(2)LEN, WAO guideline: definition, classification and diagnosis of urticaria, pp.Allergy, 2009[DOI]
3. Zuberbier T, "EAACI", GA(2)LEN, WAO guideline: management of urticaria, pp.Allergy, 2009[DOI]
4. MacGlashan DW Jr, "Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody", J Immunol, 158, pp.1438~1445 (1997)
5. Beck LA, "Omalizumab-induced reductions in mast cell Fce psilon RI expression and function", J Allergy Clin Immunol, 114, pp.527~530 (2004)
6. Młynek A, "How to assess disease activity in patients with chronic urticaria?", Allergy, 63, pp.777~780 (2008)
7. Finlay AY, "Dermatology Life Quality Index (DQLI)- -a simple practical measure for routine clinical use", Clin Exp Dermatol, 19, pp.210~216 (1994)
8. Ivyanskiy I, "Omalizumab for chronic urticaria: a case series and overview of the literature", Case Rep Dermatol, 4, pp.19~26 (2012)
9. Hamilton RG, "Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy", J Immunol Methods, 303, pp.81~91 (2005)
10. Steiss JO, "Immunoglobulin E monitoring and reduction of omalizumab therapy in children and adolescents", Allergy Asthma Proc, 33, pp.77~81 (2012)

관련 논문AI추천